[1] |
Pan M,, Lyu C, ZhaoJ, et al. Sixty years (1957—2017) of research on toxoplasmosis in China: an overview[J]. Front Microbiol, 2017, 8: 1825.
doi: 10.3389/fmicb.2017.01825
|
[2] |
Shen JL,, Wang L. Genotypes and main effectors of Toxoplasma gondii and their pathogenic mechanisms[J]. Chin J Parasitol Parasit Dis, 2015, 33(6): 429-435. (in Chinese)
|
|
( 沈继龙,, 王林. 弓形虫的基因型及其主要效应分子的致病机制[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 429-435.)
|
[3] |
Montoya JG,, Liesenfeld O. Toxoplasmosis[J]. Lancet, 2004, 363(9425): 1965-1976.
pmid: 15194258
|
[4] |
Zeng JL,, Na RH,, Chen AY, et al. Observation of the feline intestinal epithelial cell infected with Toxoplasma gondii[J]. Chin J Parasitol Parasit Dis, 2015, 33(1): 32-34. (in Chinese)
|
|
( 曾俊岭,, 娜仁花,, 陈艾媛, 等. 刚地弓形虫感染猫肠上皮细胞的初步观察[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(1): 32-34.)
|
[5] |
Xu XQ,, Liao DJ,, Feng X, et al. Status of Toxoplasma infection in pregnant and postpartum women in Duyun District of Guizhou Province during 2015—2018[J]. Chin J Parasitol Parasit Dis, 2020, 38(2): 165-167. (in Chinese)
|
|
( 徐晓青,, 廖德君,, 冯霞, 等. 2015—2018年贵州省都匀地区孕产妇弓形虫感染情况调查[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(2): 165-167.)
|
[6] |
Opsteegh M,, Kortbeek TM,, Havelaar AH, et al. Intervention strategies to reduce human Toxoplasma gondii disease burden[J]. Clin Infect Dis, 2015, 60(1): 101-107.
doi: 10.1093/cid/ciu721
pmid: 25225234
|
[7] |
Osipyan A,, Chen D,, Dekker FJ. Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation[J]. Drug Discov Today, 2021, 26(7): 1728-1734.
doi: 10.1016/j.drudis.2021.03.012
|
[8] |
Bernhagen J,, Krohn R,, Lue HQ, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment[J]. Nat Med, 2007, 13(5): 587-596.
doi: 10.1038/nm1567
pmid: 17435771
|
[9] |
Kang I,, Bucala R. The immunobiology of MIF: function, genetics and prospects for precision medicine[J]. Nat Rev Rheumatol, 2019, 15(7): 427-437.
doi: 10.1038/s41584-019-0238-2
|
[10] |
Sommerville C,, Richardson JM,, Williams RAM, et al. Biochemical and immunological characterization of Toxoplasma gondii macroph-age migration inhibitory factor[J]. J Biol Chem, 2013, 288(18): 12733-12741.
doi: 10.1074/jbc.M112.419911
pmid: 23443656
|
[11] |
Rosado J,, Rodriguez-Sosa M. Macrophage migration inhibitory factor (MIF): a key player in protozoan infections[J]. Int J Biol Sci, 2011, 7(9): 1239-1256.
doi: 10.7150/ijbs.7.1239
pmid: 22110378
|
[12] |
Holowka T,, Castilho TM,, Garcia AB, et al. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence[J]. FASEB J, 2016, 30(6): 2249-2265.
doi: 10.1096/fj.201500189R
pmid: 26956417
|
[13] |
Shen B,, Brown KM,, Lee TD, et al. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9[J]. mBio, 2014, 5(3): e01114-e01114.
|
[14] |
Fu YX,, Kong QM,, Lu SH. Research development of CRISPR/Cas9 system on parasitic studies[J]. Chin J Parasitol Parasit Dis, 2017, 35(3): 299-304. (in Chinese)
|
|
( 付益修,, 孔庆明,, 陆绍红. CRISPR/Cas9系统在寄生虫领域的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(3): 299-304.)
|
[15] |
Leng L,, Metz CN,, Fang Y, et al. MIF signal transduction initiated by binding to CD74[J]. J Exp Med, 2003, 197(11): 1467-1476.
doi: 10.1084/jem.20030286
pmid: 12782713
|
[16] |
Marcon CF,, Ferreira PTM,, Franco PS, et al. Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection[J]. Cytokine, 2020, 136: 155283.
doi: 10.1016/j.cyto.2020.155283
|
[17] |
Kwon HJ,, Won YS,, Suh HW, et al. Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesis[J]. J Immunol, 2010, 185(7): 3980-3989.
doi: 10.4049/jimmunol.1000990
|
[18] |
Ghosh S,, Jiang N,, Farr L, et al. Parasite-produced MIF cytokine: role in immune evasion, invasion, and pathogenesis[J]. Front Immunol, 2019, 10: 1995.
doi: 10.3389/fimmu.2019.01995
|
[19] |
Kamir D,, Zierow S,, Leng L, et al. A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses[J]. J Immunol, 2008, 180(12): 8250-8261.
doi: 10.4049/jimmunol.180.12.8250
|
[20] |
Liang L,, Liu HP,, Cao JP. Functional roles of macrophage migration inhibitory factor in anti-parasitic diseases[J]. Chin J Parasitol Parasit Dis, 2012, 30(1): 56-60. (in Chinese)
|
|
( 梁乐,, 刘海鹏,, 曹建平. 巨噬细胞迁移抑制因子的抗寄生虫病作用研究[J]. 中国寄生虫学与寄生虫病杂志, 2012, 30(1): 56-60.)
|
[21] |
Liu K,, Wen HY,, Cai HJ, et al. Protective effect against toxoplasmosis in BALB/c mice vaccinated with Toxoplasma gondii macrophage migration inhibitory factor[J]. Front Microbiol, 2019, 10: 813.
doi: 10.3389/fmicb.2019.00813
|